Metric Analysis: Cabaletta Bio Inc (CABA)’s Key Ratios in the Limelight

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Cabaletta Bio Inc (NASDAQ: CABA) closed at $4.26 down -6.17% from its previous closing price of $4.54. In other words, the price has decreased by -$6.17 from its previous closing price. On the day, 0.89 million shares were traded. CABA stock price reached its highest trading level at $4.58 during the session, while it also had its lowest trading level at $4.225.

Ratios:

For a deeper understanding of Cabaletta Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.52 and its Current Ratio is at 11.52. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $36.

On November 29, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $38.

On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $40.Cantor Fitzgerald initiated its Overweight rating on October 24, 2023, with a $40 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 19 ’24 when Binder Gwendolyn sold 11,000 shares for $19.59 per share. The transaction valued at 215,439 led to the insider holds 20,000 shares of the business.

Binder Gwendolyn sold 11,000 shares of CABA for $240,789 on Dec 19 ’23. The insider now owns 20,000 shares after completing the transaction at $21.89 per share. On Nov 20 ’23, another insider, Binder Gwendolyn, who serves as the insider of the company, sold 11,000 shares for $17.82 each. As a result, the insider received 196,014 and left with 20,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 208095472 and an Enterprise Value of 12270347.

Stock Price History:

Over the past 52 weeks, CABA has reached a high of $26.35, while it has fallen to a 52-week low of $3.47. The 50-Day Moving Average of the stock is -33.35%, while the 200-Day Moving Average is calculated to be -70.85%.

Shares Statistics:

For the past three months, CABA has traded an average of 1.28M shares per day and 735210 over the past ten days. A total of 47.82M shares are outstanding, with a floating share count of 41.14M. Insiders hold about 15.78% of the company’s shares, while institutions hold 97.24% stake in the company. Shares short for CABA as of 1723680000 were 6282321 with a Short Ratio of 4.90, compared to 1721001600 on 7510383. Therefore, it implies a Short% of Shares Outstanding of 6282321 and a Short% of Float of 13.29.

Most Popular